These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Secondary progressive multiple sclerosis in childhood--interferon beta 1b treatment]. Higurashi N; Hamano S; Eto Y No To Hattatsu; 2006 May; 38(3):209-13. PubMed ID: 16715936 [TBL] [Abstract][Full Text] [Related]
4. [Acute Psychosis after Consumption of Synthetic Cannabinoids]. Mörkl S; Blesl C; Wurm WE; Tmava A Fortschr Neurol Psychiatr; 2016 Mar; 84(3):150-4. PubMed ID: 27029042 [TBL] [Abstract][Full Text] [Related]
5. Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis. McCormack PL; Scott LJ CNS Drugs; 2004; 18(8):521-46. PubMed ID: 15182221 [TBL] [Abstract][Full Text] [Related]
6. Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study. Panitch H; Miller A; Paty D; Weinshenker B; Neurology; 2004 Nov; 63(10):1788-95. PubMed ID: 15557491 [TBL] [Abstract][Full Text] [Related]
7. A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis. Montalban X; Sastre-Garriga J; Tintoré M; Brieva L; Aymerich FX; Río J; Porcel J; Borràs C; Nos C; Rovira A Mult Scler; 2009 Oct; 15(10):1195-205. PubMed ID: 19797261 [TBL] [Abstract][Full Text] [Related]
8. Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: a comparative study. Mitchell J; Vierkant AD J Psychol; 1991 May; 125(3):301-10. PubMed ID: 1880755 [TBL] [Abstract][Full Text] [Related]
9. Spotlight on Interferon-beta-1b in relapsing-remitting and secondary progressive multiple sclerosis. McCormack PL; Scott LJ BioDrugs; 2004; 18(5):343-7. PubMed ID: 15377176 [TBL] [Abstract][Full Text] [Related]
10. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. McKetin R; Baker AL; Dawe S; Voce A; Lubman DI Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630 [TBL] [Abstract][Full Text] [Related]
11. Psychosis associated with clonazepam therapy for blepharospasm. White MC; Silverman JJ; Harbison JW J Nerv Ment Dis; 1982 Feb; 170(2):117-9. PubMed ID: 7057171 [TBL] [Abstract][Full Text] [Related]
13. Interferon-beta 1b in the treatment of multiple sclerosis. Río J; Montalban X Expert Opin Pharmacother; 2005 Dec; 6(16):2877-86. PubMed ID: 16318438 [TBL] [Abstract][Full Text] [Related]
14. Interferon β for secondary progressive multiple sclerosis: a systematic review. La Mantia L; Vacchi L; Rovaris M; Di Pietrantonj C; Ebers G; Fredrikson S; Filippini G J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):420-6. PubMed ID: 22952326 [TBL] [Abstract][Full Text] [Related]
15. Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up. Tur C; Montalban X; Tintoré M; Nos C; Río J; Aymerich FX; Brieva L; Téllez N; Perkal H; Comabella M; Galán I; Calle D; Sastre-Garriga J; Rovira A Arch Neurol; 2011 Nov; 68(11):1421-7. PubMed ID: 22084124 [TBL] [Abstract][Full Text] [Related]
16. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants. Mahoney JJ; Kalechstein AD; De La Garza R; Newton TF Am J Addict; 2008; 17(2):83-98. PubMed ID: 18393050 [TBL] [Abstract][Full Text] [Related]
17. [An unusual case of psychosis caused by long-term administration of a scopolamine membrane patch. Paranoid hallucinogenic and delusional symptoms]. Rubner O; Kummerhoff PW; Haase H Nervenarzt; 1997 Jan; 68(1):77-9. PubMed ID: 9132625 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study. Fernández O; Guerrero M; Mayorga C; Muñoz L; Leán A; Luque G; Hervás M; Fernández V; Capdevila A; de Ramón E J Neurol; 2002 Aug; 249(8):1058-62. PubMed ID: 12195454 [TBL] [Abstract][Full Text] [Related]
19. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Wynn D; Kaufman M; Montalban X; Vollmer T; Simon J; Elkins J; O'Neill G; Neyer L; Sheridan J; Wang C; Fong A; Rose JW; Lancet Neurol; 2010 Apr; 9(4):381-90. PubMed ID: 20163990 [TBL] [Abstract][Full Text] [Related]
20. Prolonged psychosis associated with interferon therapy in a patient with hepatitis C: case study and literature review. Cheng YC; Chen CC; Ho AS; Chiu NY Psychosomatics; 2009; 50(5):538-42. PubMed ID: 19855041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]